{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:36:05Z","timestamp":1792704965414,"version":"4.5.0"},"reference-count":105,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T00:00:00Z","timestamp":1641081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Non-alcoholic steatohepatitis (NASH) is characterized by steatosis, lobular inflammation, and enlargement of the diameter of hepatocytes (ballooning hepatocytes), with or without fibrosis. It affects 20% of patients with non-alcoholic fatty liver disease (NAFLD). Due to liver dysfunction and the numerous metabolic changes that commonly accompany the condition (obesity, insulin resistance, type 2 diabetes, and metabolic syndrome), the secretion of organokines is modified, which may contribute to the pathogenesis or progression of the disease. In this sense, this study aimed to perform a review of the role of organokines in NASH. Thus, by combining descriptors such as NASH, organokines, oxidative stress, inflammation, insulin resistance, and dyslipidemia, a search was carried out in the EMBASE, MEDLINE-PubMed, and Cochrane databases of articles published in the last ten years. Insulin resistance, inflammation and mitochondrial dysfunction, fructose, and intestinal microbiota were factors identified as participating in the genesis and progression of NASH. Changes in the pattern of organokines secretion (adipokines, myokines, hepatokines, and osteokines) directly or indirectly contribute to aggravating the condition or compromise homeostasis. Thus, further studies involving skeletal muscle, adipose, bone, and liver tissue as endocrine organs are essential to better understand the modulation of organokines involved in the pathogenesis of NASH to advance in the treatment of this disease.<\/jats:p>","DOI":"10.3390\/ijms23010498","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T01:15:26Z","timestamp":1641518126000},"page":"498","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future"],"prefix":"10.3390","volume":"23","author":[{"given":"Jo\u00e3o Paulo Margiotti dos","family":"Santos","sequence":"first","affiliation":[{"name":"Faculty of Medicine of Marilia (FAMEMA), School of Medicine, Avenida Monte Carmelo, 800, Marilia 17519-030, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Canevari de","family":"Maio","sequence":"additional","affiliation":[{"name":"Faculty of Medicine of Marilia (FAMEMA), School of Medicine, Avenida Monte Carmelo, 800, Marilia 17519-030, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8769-0993","authenticated-orcid":false,"given":"Monike Alves","family":"Lemes","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3159-0982","authenticated-orcid":false,"given":"Lucas Fornari","family":"Laurindo","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesselina Francisco dos Santos","family":"Haber","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902, SP, Brazil"},{"name":"Interdisciplinary Center on Diabetes (CENID)-UNIMAR-Mar\u00edlia, Marilia 17525-902, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Dib","family":"Bechara","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Pedro Sidnei do","family":"Prado","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein Intensive Care Unit, Morumbi 05652-900l, SP, Brazil"},{"name":"Americas Servi\u00e7os Medicos, Intensive Care Unit, Samaritano Hospital, Sao Paulo 01232-010, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Costa","family":"Rauen","sequence":"additional","affiliation":[{"name":"Rauen Institute, Sao Paulo 05670-000, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Costa","sequence":"additional","affiliation":[{"name":"Americas Servi\u00e7os Medicos, Intensive Care Unit, Samaritano Hospital, Sao Paulo 01232-010, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Cristina de Abreu","family":"Pereira","sequence":"additional","affiliation":[{"name":"Americas Servi\u00e7os Medicos, Intensive Care Unit, Samaritano Hospital, Sao Paulo 01232-010, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8381-8830","authenticated-orcid":false,"given":"Uri Adrian Prync","family":"Flato","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902, SP, Brazil"},{"name":"Americas Servi\u00e7os Medicos, Intensive Care Unit, Samaritano Hospital, Sao Paulo 01232-010, SP, Brazil"},{"name":"Postgraduate Program in Structural and Functional Interactions in Rehabilitation-UNIMAR-Mar\u00edlia\u2013SP, Brazil, Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902l, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo de Alvares","family":"Goulart","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Structural and Functional Interactions in Rehabilitation-UNIMAR-Mar\u00edlia\u2013SP, Brazil, Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902l, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6901-9082","authenticated-orcid":false,"given":"Eduardo Federighi Baisi","family":"Chagas","sequence":"additional","affiliation":[{"name":"Interdisciplinary Center on Diabetes (CENID)-UNIMAR-Mar\u00edlia, Marilia 17525-902, SP, Brazil"},{"name":"Postgraduate Program in Structural and Functional Interactions in Rehabilitation-UNIMAR-Mar\u00edlia\u2013SP, Brazil, Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902l, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-876X","authenticated-orcid":false,"given":"Sandra Maria","family":"Barbalho","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902, SP, Brazil"},{"name":"Interdisciplinary Center on Diabetes (CENID)-UNIMAR-Mar\u00edlia, Marilia 17525-902, SP, Brazil"},{"name":"Postgraduate Program in Structural and Functional Interactions in Rehabilitation-UNIMAR-Mar\u00edlia\u2013SP, Brazil, Avenida Hygino Muzzy Filho, 1001, Marilia 17525-902l, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"101167","DOI":"10.1016\/j.molmet.2021.101167","article-title":"Imaging biomarkers of NAFLD, NASH, and fibrosis","volume":"50","author":"Ajmera","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1530\/EC-20-0490","article-title":"Pathophysiology of NASH in endocrine diseases","volume":"10","author":"Gariani","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rinaldi, L., Pafundi, P.C., Galiero, R., Caturano, A., Morone, M.V., Silvestri, C., Giordano, M., Salvatore, T., and Sasso, F.C. (2021). Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review. Antioxidants, 10.","DOI":"10.3390\/antiox10020270"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ayada, I., van Kleef, L.A., Alferink, L.J.M., Li, P., de Knegt, R.J., and Pan, Q. (2021). Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: Focusing on the non-overlap groups. Liver. Int.","DOI":"10.1111\/liv.15139"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: When pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fmed.2020.00361","article-title":"Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD","volume":"7","author":"Jiang","year":"2020","journal-title":"Front. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.aohep.2020.03.001","article-title":"Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity","volume":"19","author":"Lonardo","year":"2020","journal-title":"Ann. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1590\/s0004-2803.201800000-62","article-title":"Correlation between nonalcoholic fatty liver disease features and levels of adipokines and inflammatory cytokines among morbidly obese individuals","volume":"55","author":"Baltieri","year":"2018","journal-title":"Arq. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic Steatohepatitis: A Review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"bqaa134","DOI":"10.1210\/endocr\/bqaa134","article-title":"NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment","volume":"161","author":"DiStefano","year":"2020","journal-title":"Endocrinology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100149","DOI":"10.1016\/j.metop.2021.100149","article-title":"Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)","volume":"12","author":"Zarghamravanbakhsh","year":"2021","journal-title":"Metab. Open"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kim, H., Lee, D.S., An, T.H., Park, H.J., Kim, W.K., Bae, K.H., and Oh, K.J. (2021). Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094495"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/bs.acc.2019.07.012","article-title":"Chapter Six\u2014Organokines in disease","volume":"Volume 94","author":"Makowski","year":"2020","journal-title":"Advances in Clinical Chemistry"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kolb, H., Kempf, K., R\u00f6hling, M., and Martin, S. (2020). Insulin: Too much of a good thing is bad. BMC Med., 18.","DOI":"10.1186\/s12916-020-01688-6"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Armandi, A., Rosso, C., Caviglia, G.P., and Bugianesi, E. (2021). Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. Metabolites, 11.","DOI":"10.3390\/metabo11030155"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving Role for Pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Rives, C., Fougerat, A., Ellero-Simatos, S., Loiseau, N., Guillou, H., Gamet-Payrastre, L., and Wahli, W. (2020). Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules, 10.","DOI":"10.3390\/biom10121702"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"773432","DOI":"10.3389\/fendo.2021.773432","article-title":"Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease","volume":"12","author":"Kimura","year":"2021","journal-title":"Front. in Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Fujii, H., Kawada, N., and Japan Study Group of NAFLD (2020). The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113863"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"656441","DOI":"10.3389\/fphys.2021.656441","article-title":"Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease","volume":"12","author":"Secor","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"767314","DOI":"10.3389\/fendo.2021.767314","article-title":"Current and Potential Therapies Targeting Inflammation in NASH","volume":"12","author":"Albhaisi","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"106005","DOI":"10.1016\/j.phrs.2021.106005","article-title":"Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases","volume":"175","author":"Xiao","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","article-title":"Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease","volume":"1061","author":"Farrell","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Longo, M., Paolini, E., Meroni, M., and Dongiovanni, P. (2021). Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD\/NASH to HCC. Int. J. Mol. Sci., 22.","DOI":"10.20944\/preprints202103.0714.v1"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cmet.2019.09.003","article-title":"Dietary Sugars Alter Hepatic Fatty Acid Oxidation via Transcriptional and Post-translational Modifications of Mitochondrial Proteins","volume":"30","author":"Softic","year":"2019","journal-title":"Cell Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1617805","DOI":"10.1155\/2020\/1617805","article-title":"Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"2020","author":"Gonzalez","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41467-020-20303-z","article-title":"Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH","volume":"12","author":"Dong","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: Is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: A major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Roeb, E., and Weiskirchen, R. (2021). Fructose and Non-Alcoholic Steatohepatitis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.634344"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ajcn\/nqz273","article-title":"Dietary sugars and cardiometabolic risk factors: A network meta-analysis on isocaloric substitution interventions","volume":"111","author":"Schwingshackl","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Jegatheesan, P., and De Bandt, J.-P. (2017). Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism. Nutrients, 9.","DOI":"10.3390\/nu9030230"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00018-019-03390-0","article-title":"Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis","volume":"77","author":"DiStefano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s42255-020-0261-2","article-title":"Fructose stimulated de novo lipogenesis is promoted by inflammation","volume":"2","author":"Todoric","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Muriel, P., L\u00f3pez-S\u00e1nchez, P., and Ramos-Tovar, E. (2021). Fructose and the Liver. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136969"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jand.2016.06.003","article-title":"Added Sugars Intake Across the Distribution of US Children and Adult Consumers: 1977\u20132012","volume":"116","author":"Powell","year":"2016","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOL.0000000000000042","article-title":"Fructose vs. glucose and metabolism: Do the metabolic differences matter?","volume":"25","author":"Sievenpiper","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Chan, A.M.L., Ng, A.M.H., Mohd Yunus, M.H., Idrus, R.B.H., Law, J.X., Yazid, M.D., Chin, K.-Y., Shamsuddin, S.A., and Lokanathan, Y. (2021). Recent Developments in Rodent Models of High-Fructose Diet-Induced Metabolic Syndrome: A Systematic Review. Nutrients, 13.","DOI":"10.3390\/nu13082497"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clinre.2019.09.002","article-title":"Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid","volume":"44","author":"Eshraghian","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3748\/wjg.v26.i15.1683","article-title":"Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review","volume":"26","author":"Brennan","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"107874","DOI":"10.1016\/j.jdiacomp.2021.107874","article-title":"Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population","volume":"35","author":"Cui","year":"2021","journal-title":"J. Diabetes Complicat."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Federico, A., Rosato, V., Masarone, M., Torre, P., Dallio, M., Romeo, M., and Persico, M. (2021). The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights. Nutrients, 13.","DOI":"10.3390\/nu13041314"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Montes de Oca, A., Juli\u00e1n, M.T., Ramos, A., Puig-Domingo, M., and Alonso, N. (2020). Microbiota, Fiber, and NAFLD: Is There Any Connection?. Nutrients, 12.","DOI":"10.3390\/nu12103100"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Carter, J.K., Bhattacharya, D., Borgerding, J.N., Fiel, M.I., Faith, J.J., and Friedman, S.L. (2021). Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0244763"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/19490976.2016.1270811","article-title":"Western diets, gut dysbiosis, and metabolic diseases: Are they linked?","volume":"8","author":"Martinez","year":"2017","journal-title":"Gut Microb."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Tsai, M.-C., Liu, Y.-Y., Lin, C.-C., Wang, C.-C., Wu, Y.-J., Yong, C.-C., Chen, K.-D., Chuah, S.-K., Yao, C.-C., and Huang, P.-Y. (2020). Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. Nutrients, 12.","DOI":"10.3390\/nu12030820"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Ferro, D., Baratta, F., Pastori, D., Cocomello, N., Colantoni, A., Angelico, F., and Del Ben, M. (2020). New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. Nutrients, 12.","DOI":"10.3390\/nu12092762"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nutres.2021.04.008","article-title":"A rise in Proteobacteria is an indicator of gut-liver axis-mediated nonalcoholic fatty liver disease in high-fructose-fed adult mice","volume":"91","author":"Miranda","year":"2021","journal-title":"Nutr. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: Beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver. Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.cmet.2020.08.001","article-title":"A Membrane-Bound Diacylglycerol Species Induces PKC\u03f5-Mediated Hepatic Insulin Resistance","volume":"32","author":"Lyu","year":"2020","journal-title":"Cell Metab."},{"key":"ref_55","first-page":"6613827","article-title":"NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2","volume":"2021","author":"Knobloch","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(20)30186-2","article-title":"Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: A multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"5","author":"Loomba","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","article-title":"Muscle, Bone, and Fat Crosstalk: The Biological Role of Myokines, Osteokines, and Adipokines","volume":"18","author":"Kirk","year":"2020","journal-title":"Curr. Osteoporos Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","article-title":"Hepatokines and adipokines in NASH-related hepatocellular carcinoma","volume":"74","author":"Kucukoglu","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3803\/EnM.2016.31.1.1","article-title":"The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis","volume":"31","author":"Choi","year":"2016","journal-title":"Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","article-title":"Adipokines in health and disease","volume":"36","author":"Fasshauer","year":"2015","journal-title":"Trends Pharm. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Adolph, T.E., Grander, C., Grabherr, F., and Tilg, H. (2017). Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081649"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Albhaisi, S., and Sanyal, A. (2018). Recent advances in understanding and managing non-alcoholic fatty liver disease. F1000Research, 7.","DOI":"10.12688\/f1000research.14421.1"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Petta, S., Gastaldelli, A., Rebelos, E., Bugianesi, E., Messa, P., Miele, L., Svegliati-Baroni, G., Valenti, L., and Bonino, F. (2016). Pathophysiology of Non Alcoholic Fatty Liver Disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17122082"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"de Oliveira dos Santos, A.R., de Oliveira Zanuso, B., Miola, V.F.B., Barbalho, S.M., Santos Bueno, P.C., Flato, U.A.P., Detregiachi, C.R.P., Buchaim, D.V., Buchaim, R.L., and Tofano, R.J. (2021). Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052639"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/17474124.2016.1110485","article-title":"Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines","volume":"10","author":"Panera","year":"2016","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3389\/fmed.2021.683250","article-title":"Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD","volume":"8","author":"Marques","year":"2021","journal-title":"Front. Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Cortegana, C., Garc\u00eda-Galey, A., Tami, M., del Pino, P., Carmona, I., L\u00f3pez, S., Alba, G., and S\u00e1nchez-Margalet, V. (2021). Role of Leptin in Non-Alcoholic Fatty Liver Disease. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070762"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zorena, K., Jachimowicz-Duda, O., \u015al\u0119zak, D., Robakowska, M., and Mrugacz, M. (2020). Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103570"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2174\/0929866527666200505214555","article-title":"Adipokines: A Rainbow of Proteins with Metabolic and Endocrine Functions","volume":"27","author":"Parrettini","year":"2020","journal-title":"Protein Pept. Lett."},{"key":"ref_70","first-page":"484","article-title":"Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis","volume":"9","author":"Han","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"101178","DOI":"10.1016\/j.tranon.2021.101178","article-title":"Resistin: A journey from metabolism to cancer","volume":"14","author":"Deb","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2018.09.002","article-title":"Myokines, physical activity, insulin resistance and autoimmune diseases","volume":"203","author":"Gannar","year":"2018","journal-title":"Immunol. Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"154818","DOI":"10.1016\/j.metabol.2021.154818","article-title":"Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis","volume":"121","author":"Polyzos","year":"2021","journal-title":"Metabolism"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.metabol.2013.09.013","article-title":"Irisin in patients with nonalcoholic fatty liver disease","volume":"63","author":"Polyzos","year":"2014","journal-title":"Metabolism"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Gonzalez-Gil, A.M., and Elizondo-Montemayor, L. (2020). The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review. Nutrients, 12.","DOI":"10.3390\/nu12061899"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.dld.2019.03.002","article-title":"Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation","volume":"51","author":"Delogu","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2478\/jtim-2019-0029","article-title":"Role of Hepatokines in Non-alcoholic Fatty Liver Disease","volume":"7","author":"Ke","year":"2019","journal-title":"J. Transl. Int. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.18388\/abp.2016_1252","article-title":"Hepatokines and non-alcoholic fatty liver disease","volume":"63","author":"Lebensztejn","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Barja-Fern\u00e1ndez, S., Folgueira, C., Castelao, C., Pena-Le\u00f3n, V., Gonz\u00e1lez-Saenz, P., V\u00e1zquez-Cobela, R., Aguilera, C.M., Gil-Campos, M., Bueno, G., and Gil, \u00c1. (2019). ANGPTL-4 is Associated with Obesity and Lipid Profile in Children and Adolescents. Nutrients, 11.","DOI":"10.3390\/nu11061340"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41598-020-80689-0","article-title":"LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH","volume":"11","author":"Takata","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/jc.2018-00740","article-title":"Sex Hormone-Binding Globulin Expression Correlates With Acetyl-Coenzyme A Carboxylase and Triglyceride Content in Human Liver","volume":"104","author":"Hernandez","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bpobgyn.2016.03.003","article-title":"Hepatic manifestations of women with polycystic ovary syndrome","volume":"37","author":"Chen","year":"2016","journal-title":"Best Pr. Res. Clin. Obs. Gynaecol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2337\/db20-0884","article-title":"Emerging Role of Bone Morphogenetic Protein 4 in Metabolic Disorders","volume":"70","author":"Baboota","year":"2021","journal-title":"Diabetes"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11914-020-00600-8","article-title":"Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases","volume":"18","author":"Colaianni","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cell.2013.08.042","article-title":"Maternal and offspring pools of osteocalcin influence brain development and functions","volume":"155","author":"Oury","year":"2013","journal-title":"Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.cmet.2019.08.012","article-title":"Mediation of the Acute Stress Response by the Skeleton","volume":"30","author":"Berger","year":"2019","journal-title":"Cell Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jbmr.4227","article-title":"Osteocalcin and Non-Alcoholic Fatty Liver Disease: Lessons From Two Population-Based Cohorts and Animal Models","volume":"36","author":"Xia","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Barbalho, S.M., Flato, U.A.P., Tofano, R.J., Goulart, R.d.A., Guiguer, E.L., Detregiachi, C.R.P., Buchaim, D.V., Ara\u00fajo, A.C., Buchaim, R.L., and Reina, F.T.R. (2020). Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103607"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11926-019-0868-z","article-title":"Adipokines: New Therapeutic Target for Osteoarthritis?","volume":"21","author":"Xie","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"170422","DOI":"10.1016\/j.peptides.2020.170422","article-title":"Chemerin\/CMKLR1 ameliorates nonalcoholic steatohepatitis by promoting autophagy and alleviating oxidative stress through the JAK2-STAT3 pathway","volume":"135","author":"An","year":"2021","journal-title":"Peptides"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jhep.2016.05.041","article-title":"Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2","volume":"65","author":"Ye","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","article-title":"Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation","volume":"28","author":"Moschen","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41598-017-18981-9","article-title":"SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease","volume":"8","author":"Mazzolini","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/liv.14857","article-title":"SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism","volume":"41","author":"Onorato","year":"2021","journal-title":"Liver. Int."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.advms.2019.02.005","article-title":"Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?","volume":"64","author":"Wasilewska","year":"2019","journal-title":"Adv. Med. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD)\u2014Pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"ref_97","first-page":"21","article-title":"Ghrelin Reduces TNF-\u03b1-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD","volume":"104","author":"Ezquerro","year":"2019","journal-title":"J Clin. Endocrinol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.26698","article-title":"Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-018-0061-2","article-title":"You are what you eat: Diet, health and the gut microbiota","volume":"16","author":"Zmora","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Janzi, S., Gonz\u00e1lez-Padilla, E., Najafi, K., Ramne, S., Ahlqvist, E., Born\u00e9, Y., and Sonestedt, E. (2021). Single Nucleotide Polymorphisms in Close Proximity to the Fibroblast Growth Factor 21 (FGF21) Gene Found to be Associated with Sugar Intake in a Swedish Population. Nutrients, 13.","DOI":"10.3390\/nu13113954"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_103","first-page":"100253","article-title":"Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD","volume":"3","author":"Oh","year":"2021","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2468-1253(21)00169-2","article-title":"Sleep and liver disease: A bidirectional relationship","volume":"6","author":"Marjot","year":"2021","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Stacchiotti, A., Favero, G., and Rodella, L.F. (2020). Impact of Melatonin on Skeletal Muscle and Exercise. Cells, 9.","DOI":"10.3390\/cells9020288"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/498\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:59:56Z","timestamp":1760363996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,2]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijms23010498"],"URL":"https:\/\/doi.org\/10.3390\/ijms23010498","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,2]]}}}